These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15166923)

  • 21. Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well-considered choice.
    Depreter B; Devreese KM
    Clin Chem Lab Med; 2017 Jan; 55(1):91-101. PubMed ID: 27331311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 23. Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):242-4. PubMed ID: 20182349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulants.
    Mant MJ; Stang L; Etches WS
    Thromb Res; 2000 Sep; 99(5):477-82. PubMed ID: 10973677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lupus anticoagulant testing with optical end point automation.
    Luddington R; Scales C; Baglin T
    Thromb Res; 1999 Nov; 96(3):197-203. PubMed ID: 10588462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy.
    Moore GW; Rangarajan S; Holland LJ; Henley A; Savidge GF
    Br J Biomed Sci; 2005; 62(1):15-8; quiz 47. PubMed ID: 15816206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
    Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
    Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different Anticoagulants.
    Khan W; Tormey CA; Rinder HM; Siddon AJ
    Am J Clin Pathol; 2023 May; 159(5):417-419. PubMed ID: 36940149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays.
    Hillarp A; Strandberg K; Gustafsson KM; Lindahl TL
    J Thromb Haemost; 2020 Aug; 18(8):1866-1873. PubMed ID: 32294291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin monitoring by an anticoagulant therapy factor (ATF).
    Carroll WE; Jackson RD; Carroll TA
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):159-70. PubMed ID: 9821212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation assays for the lupus anticoagulant: review and critique of current methodology.
    Triplett DA
    Stroke; 1992 Feb; 23(2 Suppl):I11-4. PubMed ID: 1561667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
    Sanfelippo MJ; Sennet J; McMahon EJ
    WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT).
    Pengo V; Bison E; Banzato A; Zoppellaro G; Jose SP; Denas G
    Methods Mol Biol; 2017; 1646():169-176. PubMed ID: 28804828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
    Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
    Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test].
    Sato K; Kagami K; Asai M; Nakashima N; Takamatsu J
    Rinsho Byori; 1995 Mar; 43(3):263-8. PubMed ID: 7745832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.